Acute vascular events as a possibly related adverse event of immunotherapy: a single-institute retrospective study-Reference-Cited by-同舟云学术

Acute vascular events as a possibly related adverse event of immunotherapy: a single-institute retrospective study

Published:2019-10 Issue: Volume:120 Page:122-131
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Bar Jair^ORCID,Markel Gal,Gottfried Teodor,Percik Ruth^ORCID,Leibowitz-Amit Raya,Berger Raanan,Golan Talia,Daher Sameh,Taliansky Alisa,Dudnik Elizabeth,Shulman Katerina,Urban Damien,Onn Amir

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference37 articles.

1. Development of immuno-oncology drugs — from CTLA4 to PD1 to the next generations;Hoos;Nat Rev Drug Discov,2016

2. Pooled analysis of long-term survival data from phase II and phase III trials of ipilimumab in unresectable or metastatic melanoma;Schadendorf;J Clin Oncol,2015

3. Five-year follow-up of nivolumab in previously treated advanced non–small-cell lung cancer: Results from the CA209-003 study;Gettinger;J Clin Oncol,2018

4. Managing toxicities associated with immune checkpoint inhibitors: consensus recommendations from the society for immunotherapy of cancer (SITC) toxicity management working group;Puzanov;J Immunother Cancer,2017

5. Current diagnosis and Management of Immune Related Adverse Events (irAEs) induced by immune checkpoint inhibitor therapy;Kumar;Front Pharmacol,2017

Cited by 82 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Thrombotic events associated with immune checkpoint inhibitors and novel antithrombotic strategies to mitigate bleeding risk;Blood Reviews;2024-09

2. Arterial inflammation on [18F]FDG PET/CT in melanoma patients treated with and without immune checkpoint inhibitors: CHECK-FLAME I;Atherosclerosis;2024-09

3. New drugs, old problems: immune checkpoint inhibitors and cancer-associated thrombosis;Bleeding, Thrombosis and Vascular Biology;2024-05-16

4. Incidence of thromboembolic events in non-small cell lung cancer patients treated with immune checkpoint inhibitors: A systematic review and meta-analysis;Journal of Cancer Research and Therapeutics;2024-04

5. Prognostic value of anticoagulants in resectable gastric cancer;2024-03-08